YY/T 1256-2024Ureaplasma nucleic acid detection kit (English PDF)
解脲脲原体核酸检测试剂盒
Open the YY/T 1256-2024 preview as PDF
This is a limited preview
Buy now to download the full PDF (20 pages)
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
February 7, 2024
Implementation date
March 1, 2025
Scope
YY/T 1256-2024 is the English-translated version of 解脲脲原体核酸检测试剂盒.
YY/T 1256 is the product standard for the Ureaplasma nucleic acid detection kit. Ureaplasma urealyticum is a genital tract organism implicated in urethritis, infertility and adverse pregnancy outcomes, and it is difficult to culture, which is why molecular detection is the practical route and why the kits are used in large numbers in Chinese laboratories. The standard stipulates the classification, the technical requirements, the labelling, the instructions for use and the packaging, transport and storage, with the corresponding test methods. It sits under the general molecular kit standard YY/T 1182. For a manufacturer or a distributor registering a Ureaplasma assay in China, this is the standard the specification and registration testing follow.
Document preview — YY/T 1256-2024
National Standard of the People's Republic of China
- ICS
- 11.100.10
- Classification
- C44
- Replacing
- YY/T 1256-2015
Issued by: National Medical Products Administration
Contents
- 1 Scope
- 2 Normative references
- 3 Terms and definitions
- 4 Categories
Foreword
This document is in accordance with the provisions of GB/T 1.1-2020 "Guidelines for standardization work Part
1.Structure and drafting rules for standardization documents" Drafting. This document replaces YY/T 1256-2015 "Ureaplasma urealyticum nucleic acid amplification detection kit" and is different from YY/T 1256-2015 except In addition to structural adjustments and editorial changes, the main technical changes are as follows:
a) Added normative references GB/T 29791.1 and GB/T 29791.2 (see Chapter 3 and Chapter 7);
b) Deleted the naming and composition (see Chapter 4, Chapter 4 of the.2015 edition);
c) Added general requirements for reagents, including appearance, nucleic acid extraction function, internal standards and/or controls (see 5.1, 5.1.1, 5.1.2, 5.1.3);
d) Added traceability of Ureaplasma urealyticum nucleic acid quantitative reagent (see 5.2.1,
5.1 of the.2015 edition);
e) Change the accuracy item of Ureaplasma urea nucleic acid quantitative reagent to divide it into two items. accuracy and positive reference conformity rate (See 5.2.4, 5.2.5, and
5.1.3 of the.2015 edition);
f) Change the limit of quantification to the limit of detection (see 5.2.7,
5.1.6 of the.2015 edition);
g) Increase the stability of the Ureaplasma urealyticum nucleic acid quantification reagent (see 5.2.9);
h) Delete the genotyping test of Ureaplasma urealyticum nucleic acid qualitative reagent (see
6.2.3 of the.2015 edition);
1 Scope
YY/T 1256 is the product standard for the Ureaplasma nucleic acid detection kit. Ureaplasma urealyticum is a genital tract organism implicated in urethritis, infertility and adverse pregnancy outcomes, and it is difficult to culture, which is why molecular detection is the practical route and why the kits are used in large numbers in Chinese laboratories. The standard stipulates the classification, the technical requirements, the labelling, the instructions for use and the packaging, transport and storage, with the corresponding test methods. It sits under the general molecular kit standard YY/T 1182. For a manufacturer or a distributor registering a Ureaplasma assay in China, this is the standard the specification and registration testing follow.
This document stipulates the classification, technical requirements, labeling, instructions for use, packaging, transportation and storage of Ureaplasma urea nucleic acid detection kits. The corresponding test methods are described. This document is applicable to the nucleic acid detection kit for detecting ureaplasma in human urinary tract, reproductive tract and respiratory tract (hereinafter referred to as the kit). The methodologies include fluorescence PCR, constant temperature amplification, and PCR membrane hybridization.
2 Normative references
The contents of the following documents constitute the essential clauses of this document through normative references in this document. For referenced documents without a date, only the version corresponding to that date applies to this document; for referenced documents without a date, the latest version (including all amendments) applies to This document.
GB/T 29791.1 Information provided by the manufacturer of in vitro diagnostic medical devices (labeling) Part
3 Terms and definitions
The terms and definitions defined in GB/T 29791.1 and the following apply to this document.
3.1 Ureaplasma It belongs to a group of the smallest prokaryotic microorganisms without cell walls, and is an obligate parasite of eukaryotic organisms. It can use its own Urease breaks down urea. Note
1.Currently, the 14 standard serotypes of Ureaplasma are divided into two major biogroups (or completely independent species) based on phenotype and genotype. Ureaplasma microtypingi Note
2.Ureaplasma urealyticum (biogroup 1) includes serotypes 1, 3, 6 and 14; Ureaplasma urealyticum (biogroup 2) includes serotypes 2, 3, 6 and 14. serotype 1, serotype 4, serotype 5, serotype 7, serotype 8, serotype 9, serotype 10, serotype 11, serotype 12 and serotype 13. Note
3.The Ureaplasma urealyticum referred to in this document includes Ureaplasma urealyticum and Ureaplasma urealyticum.
4 Categories
Can be classified as follows:
a) According to the determination of test results, it can be divided into quantitative detection kits and qualitative detection kits;
b) According to the principle of nucleic acid amplification, it can be divided into variable temperature amplification detection kit and isothermal amplification detection kit;
c) Classified according to methodology, common methodologies include. PCR fluorescent probe method, constant temperature amplification method, and PCR membrane hybridization method.
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 20 pages — is available in the English PDF.
Referenced standards
Normative references
GB/T 29791.1 · GB/T 29791.2 · GB/T 21415
Editions of YY/T 1256
| Edition | Title | Revision | Status |
|---|---|---|---|
| YY/T 1256-2024 | Ureaplasma nucleic acid detection kit | current edition | Current |
| YY/T 1256-2015 | Ureaplasma nucleic acid detection kit | previous edition | In force until 2025-03-01 |
This page sells the current edition, YY/T 1256-2024. Earlier editions are listed for reference only.
How to Buy YY/T 1256-2024
- 1Add to cart. Click the "Buy YY/T 1256-2024" button on this page. You can add more standards before checkout.
- 2Checkout. Enter your email and billing details. Payment is processed securely by Stripe (cards, Apple Pay, Google Pay supported).
- 3Instant delivery (0–9 sec). Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4Invoice included. A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
YY/T 0297-2026 — General requirements for clinical investigation of medical devices
YY/T 0492-2026 — Implantable leads
YY/T 0517-2026 — Dentistry - Posts
Secure payment via Stripe
Payments accepted
YY/T 1256-2024
$185.00